Glimlist PG 2mg/500mg/15mg Tablet SR
Marketer
Rech Elist Pharma
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimlist PG 2mg/500mg/15mg Tablet SR
Glyconia-PG 2mg/500mg/15mg Extended-Release Tablets are a triple-combination medication designed to manage blood glucose levels. This medication, used in conjunction with diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, resulting in reduced blood sugar. Always follow your physician's prescribed dosage and regimen for Glyconia-PG 2mg/500mg/15mg ER Tablets. Administer this medication with food to mitigate gastrointestinal discomfort. If a dose is missed, take it promptly; however, if the next dose is imminent, omit the missed dose and resume the usual schedule. Never double the dose. Overdosage can result in hypoglycemia (low blood sugar). Concurrent use with other antidiabetic agents, alcohol consumption, or skipped meals may increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial during treatment. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, inform your doctor of any existing kidney, liver, or heart conditions. Pregnant or lactating women should consult their physician before use. Kidney function tests will be assessed before treatment initiation. Limit alcohol consumption as it may heighten the risk of adverse reactions.
Primary Ingredients of Glimlist PG 2mg/500mg/15mg Tablet SR
No text provided to rephrase.
Uses of Glimlist PG 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimlist PG 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing. The Glimlist PG 2mg/500mg/15mg Extended-Release tablet should be administered with a meal.
Common Side effects of Glimlist PG 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimlist PG 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimlist PG 2mg/500mg/15mg Extended-Release tablets should be administered with a meal.
How Glimlist PG 2mg/500mg/15mg Tablet SR works:
Glimlist PG 2mg/500mg/15mg Extended-Release tablets contain glimepiride, metformin, and pioglitazone, three antidiabetic agents with distinct modes of action. This triple combination enhances blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimlist PG 2mg/500mg/15mg SR tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
The use of Glimlist PG 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimlist PG 2mg/500mg/15mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glimlist PG 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. This medication is contraindicated in individuals with severe kidney disease. Routine monitoring of kidney function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Glimlist PG 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Glimlist PG 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimlist PG 2mg/500mg/15mg Tablet SR :
Should you forget a Glimlist PG 2mg/500mg/15mg Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimlist PG 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently